SCHEMBL6313673

SCHEMBL6313673

COC(=O)c1c(O)c2cc(Cl)ccc2[nH]c1=O

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.56
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIN2B Q13224 1/20 0.55
GRIN2C Q14957 1/20 0.55
GRIN3A Q8TCU5 1/20 0.55
ALOX5 P09917 1/20 0.54
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 1/20 0.52
NR4A2 P43354 1/20 0.51
CSF1R P07333 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30037913 0.89 MEN1 (0.64) MEN1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL8018550 0.89 MEN1 (0.64) MEN1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL11383585 0.85 CSF1R (0.69) GSK3BALOX5ALDH1A1CSF1RCYP1A2
SCHEMBL23510959 0.84 GRIN2D (0.58) GSK3BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3982399 0.83 GSK3B (0.56) GSK3BALOX5KDM4EMEN1ALDH1A1
SCHEMBL16651672 0.83 MEN1 (0.50) KDM4EMEN1ALDH1A1KMT2ANR4A2
SCHEMBL11375916 0.82 KDM4E (0.61) GSK3BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6507310 0.82 GSK3B (0.58) GSK3BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6507316 0.82 GRIN2D (0.50) GSK3BGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21465510 0.81 KDM4E (0.60) ALOX5KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921821-B2 Antagonists of melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2005-07-26 US disclosed
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MILLENNIUM PHARMACEUTICALS, INC. 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MCHR1, MCHR2, MC1R GSK3B 2231/4885GRIN2D 3759/4885GRIN3B 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.